BRNS
Barinthus Biotherapeutics
BRNS
BRNS
15 hedge funds and large institutions have $9.15M invested in Barinthus Biotherapeutics in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
Holders
15
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$38.5K | |
| 2 | +$26.9K | |
| 3 | +$616 | |
| 4 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
+$375 |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$108 |
Top Sellers
| 1 | -$257K | |
| 2 | -$21.2K | |
| 3 | -$13.2K | |
| 4 |
CCG
Catalina Capital Group
Torrance,
California
|
-$12.3K |
| 5 |
Morgan Stanley
New York
|
-$7.34K |